Carson Michael J. has filed 5 insider transactions across 1 company since January 2023.
Most recent transaction: a grant/award of 61200 shares of Nuvectis Pharma, Inc. ($NVCT) on January 06, 2026.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 6, 2026 | Nuvectis Pharma, Inc. | $NVCT | Carson Michael J. | Vice President, Finance | A | Common Stock | 61200 | $0.00 | 200,118.0000 | 21,812,716 | 44.05% | 0.28% |
| Jan. 2, 2025 | Nuvectis Pharma, Inc. | $NVCT | Carson Michael J. | Vice President, Finance | A | Common Stock | 51000 | $0.00 | 138,918.0000 | 17,113,169 | 58.01% | 0.30% |
| Jan. 3, 2023 | Nuvectis Pharma, Inc. | $NVCT | Carson Michael J. | Vice President, Finance | A | Common Stock | 28806 | $0.00 | 56,106.0000 | 12,657,651 | 105.52% | 0.23% |
| Jan. 4, 2024 | Nuvectis Pharma, Inc. | $NVCT | Carson Michael J. | Vice President, Finance | A | Common Stock | 34567 | $0.00 | 90,673.0000 | 15,556,655 | 61.61% | 0.22% |
| Nov. 7, 2024 | Nuvectis Pharma, Inc. | $NVCT | Carson Michael J. | Vice President, Finance | S | Common Stock | 2755 | $8.16 | 87,918.0000 | 17,230,559 | 3.04% | 0.02% |